SBC-014

N/A

Report date: 2022/11/25 17:28:05

Base Information

Drug NameSBC-014

Drug Alias NameGlycosylated recombinant G-CSF (Synageva)SBC-014AES-014AVI-014

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropeniaBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIndia

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAvigenics Inc

Active IndicationsN/A

Inactive IndicationsNeutropeniaBreast Neoplasms

ATC CodeN/A